Koshinski Asset Management, Inc. Eli Lilly & CO Transaction History

Koshinski Asset Management, Inc.

$1.13 Billion
Q3 2024

A detailed history of Koshinski Asset Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Koshinski Asset Management, Inc. holds 4,276 shares of LLY stock, worth $3.4 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

4,276

Previous 4,630 7.65%

Holding current value

$3.4 Million

Previous $4.19 Million 9.62%

% of portfolio

0.34%

Previous 0.4%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$772.14 - $960.02 $273,337 - $339,847	-354 Reduced 7.65%	4,276 $3.79 Million
Q2 2024 Jul 12, 2024	BUY	$724.87 - $909.04 $84,809 - $106,357	117 Added 2.59%	4,630 $4.19 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $571,473 - $764,550	965 Added 27.2%	4,513 $3.51 Million
Q4 2023 Jan 29, 2024	SELL	$525.19 - $619.13 $392,316 - $462,490	-747 Reduced 17.39%	3,548 $2.07 Million
Q3 2023 Oct 18, 2023	BUY	$434.7 - $599.3 $65,639 - $90,494	151 Added 3.64%	4,295 $2.31 Million
Q2 2023 Jul 28, 2023	SELL	$350.74 - $468.98 $279,189 - $373,308	-796 Reduced 16.11%	4,144 $1.94 Million
Q1 2023 Apr 12, 2023	SELL	$310.63 - $364.82 $33,237 - $39,035	-107 Reduced 2.12%	4,940 $1.7 Million
Q4 2022 Jan 24, 2023	SELL	$321.55 - $374.67 $5,466 - $6,369	-17 Reduced 0.34%	5,047 $0
Q3 2022 Oct 18, 2022	SELL	$296.48 - $337.87 $78,270 - $89,197	-264 Reduced 4.95%	5,064 $1.64 Million
Q2 2022 Jul 12, 2022	BUY	$278.73 - $327.27 $133,511 - $156,762	479 Added 9.88%	5,328 $1.73 Million
Q1 2022 Apr 20, 2022	BUY	$234.69 - $291.66 $8,918 - $11,083	38 Added 0.79%	4,849 $1.39 Billion
Q4 2021 Jan 14, 2022	BUY	$224.85 - $279.04 $12,141 - $15,068	54 Added 1.14%	4,811 $1.33 Billion
Q3 2021 Oct 12, 2021	BUY	$221.6 - $272.71 $207,417 - $255,256	936 Added 24.5%	4,757 $1.1 Million
Q2 2021 Jul 26, 2021	SELL	$180.55 - $233.54 $201,854 - $261,097	-1,118 Reduced 22.64%	3,821 $877,000
Q1 2021 May 06, 2021	BUY	$164.32 - $212.72 $305,963 - $396,084	1,862 Added 60.51%	4,939 $923,000
Q4 2020 Mar 30, 2021	BUY	$130.46 - $172.63 $68,882 - $91,148	528 Added 20.71%	3,077 $520,000
Q4 2020 Feb 05, 2021	BUY	$130.46 - $172.63 $332,542 - $440,033	2,549 New	2,549 $520,000
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $380,943 - $504,079	-2,920 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $9,942 - $11,500	-68 Reduced 2.28%	2,920 $451,000
Q2 2020 Jul 29, 2020	SELL	$136.42 - $164.18 $9,958 - $11,985	-73 Reduced 2.38%	2,988 $491,000
Q1 2020 Apr 30, 2020	BUY	$119.05 - $147.35 $2,619 - $3,241	22 Added 0.72%	3,061 $425,000
Q4 2019 Jan 29, 2020	BUY	$106.92 - $132.43 $130,656 - $161,829	1,222 Added 67.25%	3,039 $399,000
Q2 2019 Jul 18, 2019	SELL	$110.79 - $129.32 $36,560 - $42,675	-330 Reduced 15.37%	1,817 $201,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $372,777 - $438,785	-3,349 Reduced 60.94%	2,147 $279,000
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $458,970 - $514,185	-4,334 Reduced 44.09%	5,496 $636,000
Q3 2018 Nov 15, 2018	BUY	$85.86 - $107.31 $379,243 - $473,988	4,417 Added 81.6%	9,830 $1.06 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $24,148 - $27,714	-319 Reduced 5.57%	5,413 $462,000
Q1 2018 Apr 09, 2018	SELL	$74.21 - $87.6 $141,889 - $167,491	-1,912 Reduced 25.01%	5,732 $443,000
Q4 2017 Jan 17, 2018	BUY	$81.94 - $87.89 $106,276 - $113,993	1,297 Added 20.43%	7,644 $646,000
Q3 2017 Oct 12, 2017	BUY	$77.07 - $85.54 $10,173 - $11,291	132 Added 2.12%	6,347 $0
Q2 2017 Jan 17, 2018	BUY	N/A	283 Added 4.77%	6,215 $511,000
Q1 2017 Jan 17, 2018	BUY	N/A	2,492 Added 72.44%	5,932 $499,000
Q4 2016 Jan 17, 2018	SELL	N/A	-410 Reduced 10.65%	3,440 $253,000
Q3 2016 Jan 17, 2018	BUY	N/A	78 Added 2.07%	3,850 $309,000
Q2 2016 Jan 17, 2018	BUY	N/A	1,400 Added 59.02%	3,772 $297,000
Q1 2016 Jan 17, 2018	BUY	N/A	2,372	2,372 $248,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.

Account

Koshinski Asset Management, Inc. Eli Lilly & CO Transaction History